30th August 2012

Richmond Pharmacology presents further QT insulin data next month in San Diego!

We welcome you to attend the 2012 Annual Meeting of the American College of Clinical Pharmacology (ACCP), taking place 23rd-25th September, at the Sheraton San Diego Hotel & Marina.This topic of this year's meeting is  Translating Clinical Pharmacology Research into Optimized Patient Care  and will encompass a series of Pre-meeting Workshops and Symposia on related content such as the role of clinical pharmacology in speeding the development of new anti-infective drugs to combat drug resistance, pharmacometrics in hospital-based pharmacotherapy, innovations in drug therapies, and much more.Join Richmond Pharmacology on Day 1, Sun 23rd Sep between 6 and 8pm, where we will present further data on studies using techniques such as the euglycaemic insulin clamp to probe the effect of insulin on the QT interval in healthy Caucasian and Japanese volunteers:

  • Late changes after a euglycaemic insulin clamp can lead to significant increases in QTcF in healthy subjects
  • The impact of insulin levels on QTc interval in Thorough QT studies conducted in healthy subjects

View full program

Latest news

Richmond enrols first patients in Verve Therapeutic’s Heart-2 trial - pioneering a new approach to cardiovascular disease

June 27, 2024
Richmond enrols and doses the first patient in a clinical trial aimed at transforming the care of cardiovascular disease with single treatment gene-editing medicines.
Read more

A first of a kind trial in the fight against malaria

June 12, 2024
Richmond successfully recruits and enrols adults of sub-Saharan ancestry who all complete a first of its kind trial in the treatment of malaria.
Read more

Events

AHA Hypertension Scientific Sessions 2024

5 - 8 September 2024
Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the Hypertension 2024 Scientific Sessions
View event